APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753U956. A total of 4 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,932,884 | -75.8% | 77,100 | -58.1% | 0.00% | -100.0% |
| Q1 2023 | $12,123,000 | +294.4% | 183,800 | +308.4% | 0.00% | – |
| Q3 2022 | $3,074,000 | +39.7% | 45,000 | +3.9% | 0.00% | – |
| Q1 2022 | $2,200,000 | +29.1% | 43,300 | -16.2% | 0.00% | – |
| Q3 2021 | $1,704,000 | -18.9% | 51,700 | -24.6% | 0.00% | – |
| Q4 2019 | $2,101,000 | – | 68,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 96,800 | $4,377,000 | 0.01% |
| JANE STREET GROUP, LLC | 130,000 | $5,879,000 | 0.00% |
| SIMPLEX TRADING, LLC | 18,000 | $813,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |